Posts by Anjali J. Kaimal, MD, MAS
-
Risk Score for Maternal Morbidity Can Also Predict Postpartum Hemorrhage
Maternal-fetal medicine specialists at Massachusetts General Hospital found that the Expanded Obstetric Comorbidity Score (EOCS), a risk-stratification tool recently developed for predicting severe maternal morbidity, can also be used to predict which women in labor are at risk of postpartum hemorrhage.
-
Consensus Statement: Counseling Women at Increased Risk of Maternal Morbidity and Mortality
Anjali Kaimal, MD, MAS, chief of the Division of Maternal–Fetal Medicine, co-authored guidance from the Society for Maternal–Fetal Medicine about counseling reproductive-aged women who may be at high risk of adverse maternal, fetal or neonatal health outcomes during or after pregnancy.
-
Healthy Women Had Negative Childbirth Experiences at the Outbreak of COVID-19
Women not infected with SARS-CoV-2 who gave birth early in the COVID-19 pandemic were significantly more likely than matched controls to have a clinically significant acute stress response, Massachusetts General Hospital physicians have determined, and to have problems with maternal bonding and breastfeeding.
-
OB/GYN Research in the Deborah Kelly Center for Clinical Research
Anjali J. Kaimal, MD, MAS, director of the Deborah Kelly Center for Clinical Research in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital, discusses how the center facilitates and supports obstetrics and gynecologic research.
-
Influence of COVID-19 on Delivery and Inpatient Postpartum Care
Massachusetts General Hospital physicians suggest that if COVID-19 in pregnant women is not improved by treatment, then delivery may be considered even in the absence of obstetric indications.
-
Considerations for Pregnant Women and Their Neonates
Many people are asking...how does SARS-CoV-2 change peri- and postpartum care?
-
Patient and Family Preferences Strongly Influence Decisions About Trial of Labor After Cesarean
In women eligible for a trial of labor after cesarean delivery (TOLAC), predictors of undergoing TOLAC were strength of preference for vaginal delivery, value placed on the experience of labor and vaginal birth and endorsement of TOLAC by the person whose opinion the woman valued most.
-
Better Counseling Needed to Boost Number of Women Who Choose a Trial of Labor After Cesarean
Most women eligible for a trial of labor after cesarean value vaginal birth, but worries about labor interventions and complications can dampen their enthusiasm. Researchers suggest factors to consider when counseling women about the approach to delivery.
Biography
Anjali Kaimal, MD, MAS is a Maternal-Fetal Medicine Specialist at Massachusetts General Hospital and an Associate Professor in the Departments of Obstetrics, Gynecology, and Reproductive Biology and Population Medicine at Harvard Medical School. She is Chief of the Division of Maternal-Fetal Medicine, Director of the MFM Fellowship, and Obstetric Director of the Multidisciplinary Fetal Care Program.
She sees patients both at the Main Campus in Boston and in the MGH Danvers office every week. Dr. Kaimal sees women for ultrasound, prenatal diagnosis, and MFM consultation as well as caring for women on Labor and Delivery and the Antepartum Service at MGH.
Dr. Kaimal's research program is focused on the definition, design, execution, and dissemination of evidence-based, patient-centered interventions to improve the quality and effectiveness of obstetric care, particularly regarding mode of delivery and interventions during pregnancy such as induction of labor, prenatal testing, and medications for management of medical complications. She is currently the site principal investigator for an NIH funded trial to optimize shared decision making regarding mode of delivery after cesarean. She serves on the American College of Obstetricians and Gynecologists Committee on OB Practice Bulletins as well as the Society for Maternal Fetal Medicine Education Committee.
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.